A population-based study of hairy cell leukemia in Israel

European Journal of Haematology

Volumn 77, Issue 5, 2006, Pages 372-377

  Paltiel, Ora ^a   Adler, Bella ^a   Barchana, Micha ^b   Dann, Eldad J ^c,d  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b MINISTRY OF HEALTH   (Israel)

^c RAMBAM MEDICAL CENTER   (Israel)

^d TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Cancer registry; Epidemiology; Hairy cell leukemia; Second malignancy

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DEMOGRAPHY; ETHNOLOGY; FEMALE; GEOGRAPHIC ORIGIN; HAIRY CELL LEUKEMIA; HUMAN; ISRAEL; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; POPULATION RESEARCH; PRIORITY JOURNAL; PROGNOSIS; SEX DIFFERENCE; UROGENITAL TRACT TUMOR;

ADULT; AGE FACTORS; AGED; ARABS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INCIDENCE; ISRAEL; JEWS; LEUKEMIA, HAIRY CELL; MALE; MIDDLE AGED; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; UROGENITAL NEOPLASMS;

EID: 33749263161     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2006.00732.x     Document Type: Article

References (26)

1. FLINN IW, KOPECKY KJ, FOUCAR MK, et al. Long-term follow-up of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pentostatin. Blood 2000;96:2981-2986.
2. GOODMAN GR, BURIAN C, KOZIOL JA, SAVEN A. Extended follow-up of patients with hairy cell leukemia after treatment with cladribine. J Clin Oncol 2003;21:891-896.
3. DEARDEN CE, MATUTES E, HILDITCH BL, SWANSBURY GJ, CATOVSTY D. Long-term follow-up of patients with hairy cell leukemia after treatment with pentostatin or cladribine. Br J Haematol 1999;106:515-519.
4. HOUNSHELL J, TOMORI C, NEWLIN R, et al. Changes in finances, insurance, employment, and lifestyle among persons diagnosed with hairy cell leukemia. Oncologist 2001;6:435-440.
5. STEINITZ R, PARKIN DM, YOUNG JL, BIEBER CA, KATZ L (eds). Cancer incidence in Jewish migrants to Israel, 1961-1981. IARC Sci Publ 1989;98:6-7.
6. http://www.cbs.gov.il/archive/shnaton47/st02-10.gif and st02-22.gif (last accessed July 23, 2006).
7. SKJELBAKKEN T, LOCHEN M-L, DAHL IMS. Haematological malignancies in a general population, based on information collected from a population study, hospital records and the Cancer Registry of Norway. Eur J Haematol 2002;69:67-75.
8. LISHNER M, LANG R, SOREK M, RAVID M. Hairy cell leukemia in Israel. Harefuah 1985;109:1-3 (article in Hebrew).
9. BERNSTEIN L, NEWTON P, ROSS RK. Epidemiology of hairy cell leukemia in Los Angeles County. Cancer Res 1990;50:3605-3609.
10. STAINES A, CARTWRIGHT RA. Hairy cell leukemia: descriptive epidemiology and a case-control study. Br J Haematol 1993;85:714-717.
11. RUIZ-ARGUELLLES GJ, CANTU-RODRIQUEZ OG, GOMEZ-ALMAGUER D, et al. Hairy cell leukemia is infrequent in Mexico and has a geographic distribution. Am J Hematol 1996;52:316-318.
12. AU WY, KWONG YL, MA SK, et al. Hairy cell leukemia in Hong Kong Chinese: a 12-year retrospective survey. Hematol Oncol 2000;18:155-159.
13. KIRSTINSSON SY, VIDARSSON B, AGNARSSON BA, et al. Epidemiology of hairy cell leukemia in Iceland. Hematol J 2002;3:145-147.
14. FRASSOLDATI A, LAMPARELLI T, FEDERICO M, et al. Hairy cell leukemia: a clinical review based on 725 cases of the Italian Cooperative Group (ICGHCL). Italian Cooperative for Hairy Cell Leukemia. Leuk Lymphoma 1994;13:307-316.
15. ALKALAI R, BEN YEHUDA D, RONEN I, PALTIEL O. Ethnicity and prognosis in acute myeloid leukemia. Am J Hematol 2003;72:127-134.
16. ROETZHEIM R, GONZALEZ E, FERRANTE J, PAL N, VAN DURME D, KRISCHER J. Effects of health insurance and race on breast carcinoma treatments and outcomes. Cancer 2000;89:2202-2213.
17. NORDSTROM M, HARDELL L, MAGNUSON A, HAGBERG H, RASK-ANDERSEN A. Occupational exposures, animal exposure and smoking as risk factors for hairy cell leukemia evaluated in a case-control study. Br J Cancer 1998;77:2048-2052.
18. FEDERICO M, ZINZANI PL, FRASSOLDATI A, et al. Risk of second cancer in patients with hairy cell leukemia: longterm follow-up. J Clin Oncol 2002;20:638-646.
19. KURZROCK R, STROM SS, ESTEY E, et al. Second cancer risk in hairy cell leukemia: analysis of 350 patients. J Clin Oncol 1997;15:1803-1810.
20. Israel Cancer Registry. Trends in cancer incidence and mortality in Israel 1970-1995. Jerusalem: Ministry of Health, Publication no. 207, December 1998, p. 235.
21. NIELSEN B, BRAIDE I, HASSELBALCH H. Evidence for an association between hairy cell leukemia and renal cell and colorectal carcinoma. Cancer 1992;70:2087-2090.
22. AU WY, KLASA RJ, GALLAGHER R, et al. Second malignancies in patients with hairy cell leukemia in British Columbia: a 20 year experience. Blood 1998;92:1160-1164.
23. CLAVEL J, HEMON D, MANDEREAU L, DELEMOTTE B, SEVERIN F, FLANDRIN G. Farming, pesticide use and hairy-cell leukemia. Scand J Work Environ Health 1996;22:285-293.
24. HARDELL L, ERIKSSON M, NORDSTROM M. Exposure to pesticides as risk factor for non-Hodgkin's lymphomas and hairy cell leukemia: pooled analysis of two Swedish case-control studies. Leuk Lymphoma 2002;43:1043-1049.
25. NORDSTROM M, HARDELL L, FREDRIKSON M. Previous medical history and medications for hairy cell leukemia. Oncol Rep 1999;6:415-419.
26. CLAVEL J, MANDEREAU L, CORDIER S, et al. Hairy cell leukemia, occupation, and smoking. Br J Hematol 1995;91:154-161.